The most recent trading day saw AbbVie (ABBV) close at $142.66, down -0.97% as compared to previous trading session.
Shares of the pharmaceutical company had increased 1.56% over the previous month before to today's trading.
EPS of $3.59 are anticipated, up 7.81% from the same quarter last year.
Zacks Consensus Estimates anticipate $59.23 billion in revenue and earnings per share of 13.90.
PEG ratio for ABBV is 4.09. Similar to the popular P/E ratio, the PEG ratio additionally factors in the company's anticipated earnings growth rate.
The Medical sector includes the Large Cap Pharmaceuticals industry. With a Zacks Industry Rank of 99, this category is ranked in the top 40% out of more than 250 industries.